News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Letter To NovaBay Pharmaceuticals, Inc. (NBY) Shareholders


7/11/2014 9:33:40 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on non-antibiotic anti-infectives, announced today the distribution of a letter from Ron Najafi, the Company's Chairman, Chief Executive Officer, to its stockholders. A downloadable version of this letter may be obtained by visiting the CEO Blog on the NovaBay website (www.novabay.com/blog).

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES